Jefferies Group LLC Dexcom Inc Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Dexcom Inc stock. As of the latest transaction made, Jefferies Group LLC holds 9,516 shares of DXCM stock, worth $722,074. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,516

Holding current value

$722,074

% of portfolio

0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$76.35 - $94.18 $650,196 - $802,036	-8,516 Reduced 47.23%	9,516 $766,000
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $869,550 - $1.07 Million	11,389 Added 108.95%	21,842 $718,000
Q2 2022 Aug 15, 2022	SELL	$67.99 - $132.89 $657,803 - $1.29 Million	-9,675 Reduced 48.07%	10,453 $108,000
Q1 2022 Sep 21, 2023	SELL	$94.08 - $130.2 $1.18 Million - $1.63 Million	-12,518 Reduced 40.98%	18,032 $2.31 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $1.13 Million - $1.56 Million	-11,964 Reduced 37.28%	20,128 $9.33 Million
Q4 2021 Sep 21, 2023	SELL	$129.87 - $162.82 $2.81 Million - $3.52 Million	-21,646 Reduced 41.47%	30,550 $4.1 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $2.61 Million - $3.27 Million	-20,104 Reduced 38.52%	32,092 $16.8 Million
Q3 2021 Sep 21, 2023	BUY	$106.71 - $143.18 $4.43 Million - $5.94 Million	41,496 Added 387.81%	52,196 $7.14 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $4.43 Million - $5.94 Million	41,496 Added 387.81%	52,196 $28.5 Million
Q2 2021 Sep 21, 2023	BUY	$80.99 - $107.93 $56,693 - $75,551	700 Added 7.0%	10,700 $1.14 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $56,693 - $75,551	700 Added 7.0%	10,700 $4.57 Million
Q1 2021 Sep 21, 2023	SELL	$84.79 - $104.74 $211,975 - $261,850	-2,500 Reduced 20.0%	10,000 $898,000
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $211,975 - $261,850	-2,500 Reduced 20.0%	10,000 $3.59 Million
Q4 2020 Sep 21, 2023	SELL	$78.0 - $104.5 $728,676 - $976,239	-9,342 Reduced 42.77%	12,500 $1.16 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $715,260 - $958,265	9,170 Added 275.38%	12,500 $4.62 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $318,048 - $376,123	3,330 New	3,330 $1.37 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $753,074 - $1.19 Million	-15,758 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$36.62 - $57.29 $70,237 - $109,882	-1,918 Reduced 10.85%	15,758 $3.45 Million
Q3 2019 Nov 13, 2019	BUY	$35.53 - $43.8 $541,832 - $667,950	15,250 Added 628.61%	17,676 $2.64 Million
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $67,539 - $94,419	2,426 New	2,426 $364,000
Q1 2019 May 15, 2019	SELL	$28.07 - $38.18 $129,571 - $176,238	-4,616 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $1.2 Million - $1.66 Million	-44,360 Reduced 90.57%	4,616 $553,000
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $509,683 - $801,524	21,828 Added 80.4%	48,976 $7.01 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $476,175 - $684,672	27,148 New	27,148 $2.58 Million
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $235,288 - $334,016	-18,016 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $200,337 - $277,086	18,016	18,016 $1.03 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account